Which Peptides Are FDA-Approved? How to Check a Product’s Status

Some peptide medicines are FDA-approved. Many compounds discussed under the same broad “peptides” label are not. The right unit to check is the named drug product and its labeling, not the word peptide in an advertisement.

Approval and evidence answer different questions. A study can investigate an unapproved product. An approved medicine has specific uses and prescribing information; that does not establish every claim someone might make about its ingredient.

Selected examples, not a complete list

The following US examples were checked for the current guide on October 7, 2026. This is a short orientation table, not a list of every peptide drug or every indication.

Molecule	Example product	Selected label context
Semaglutide	Wegovy	Weight management for eligible patients; consult the exact formulation and current label
Tirzepatide	Zepbound	Weight management and an obstructive sleep apnea indication in eligible adults
Liraglutide	Saxenda	Weight management for eligible patients
Tesamorelin	Egrifta WR	Reduction of excess abdominal fat in adults with HIV-associated lipodystrophy; not general weight-loss management

Read the Wegovy label, Zepbound label, Saxenda label and Egrifta WR label for the complete indications, contraindications and safety information. None of these examples is a recommendation for an individual reader.

Check the actual product in FDA records

FDA’s Drugs@FDA database provides approval information and associated documents. FDA explains its scope in About Drugs@FDA.

A practical checking sequence is:

1. Write down the full brand or product name, active ingredient and manufacturer from the offer.
2. Search the FDA database and confirm that the result refers to that product.
3. Open the approval history and current prescribing information.
4. Compare the dosage form and route with what is being offered.
5. Read the indications and major safety sections, then ask a clinician how they relate to your situation.

A pharmacy listing or an ingredient name is not a substitute for a matching approval record. If you cannot reconcile the documents, ask the prescriber or pharmacist to explain the discrepancy before drawing a conclusion.

Words that can be confused with approval

Registered and listed are not synonyms for FDA-approved. FDA explains that its oversight differs between product categories and that facility registration does not itself mean a product is approved. Supplements and most cosmetics do not undergo drug-style premarket approval. FDA consumer explanation.

“Clinical trials,” “research use” and a committee discussion also describe different things from a marketing approval. In the field guide, research type is deliberately kept in a separate column from US status. A trial can have a negative result; its existence does not establish that treatment helps.

Approval is not personal suitability

Reading a label is a starting point for a discussion. It is not a way to choose your own prescription. The fact that one product is approved for one condition does not show that a different formulation is appropriate for another goal.

Use the full peptide table to compare selected compounds and follow their sources. If your question concerns a compounded product, read how compounded semaglutide differs from Ozempic. For an appointment, bring the exact product name and the claim you want to understand, rather than asking only whether “peptides” are approved.

Sources and further reading

1. FDA: About Drugs@FDA (opens in a new tab)
2. FDA: Is It Really FDA Approved? (opens in a new tab)
3. Wegovy prescribing information (opens in a new tab)
4. Zepbound prescribing information (opens in a new tab)
5. Saxenda prescribing information (opens in a new tab)
6. Egrifta WR prescribing information (opens in a new tab)

Sources were checked on October 7, 2026. Prices, labels and policies can change. Linked studies being peer reviewed does not mean this article has been clinically reviewed.